Literature DB >> 12815308

Is inappropriate implantable defibrillator shock therapy predictable?

Kumaraswamy Nanthakumar1, Paul Dorian, Miney Paquette, Mary Greene, Janet Edwards, Denis Heng, James Noble, David Newman.   

Abstract

OBJECTIVE: To identify implantable cardioverter defibrillator (ICD) patients who are at risk of receiving inappropriate shock.
BACKGROUND: Inappropriate ICD shock, usually from atrial fibrillation (AF) or sinus tachycardia (ST), is a common problem. We hypothesized that clinical variables would predict which patients with single chamber ICDs would be more likely to receive inappropriate therapy and be candidates for more accurate discriminators such as those available in dual chamber ICDs.
METHODS: The ICD registry at St. Michael's Hospital has it's clinical information and demographic data updated after each clinic visit. Inappropriate shock was considered as the outcome variable. Possible predictors considered were age, gender, ejection fraction, NYHA class, prior CABG and prior history of AF. Univariate predictors were identified using t-test for continuous variables and Chi-square test for categorical variables. Multivariate predictors were identified using stepwise logistic regression analyses.
RESULTS: Of 299 patients, 261 had complete data for analysis. In this population 78% were male, mean age was 60 +/- 13 years, mean ejection fraction was 37 +/- 15% and mean follow up was 53 +/- 36 months. One hundred and sixteen of the 261 patients (44%) received one or more inappropriate therapies (73% within 2 years of receiving their device), and 140 (51%) received one or more appropriate therapies. Significant predictors of inappropriate therapy by multivariate model were prior AF (OR 2.6, 95% CI 1.5-4.5) and NYHA class 1 vs. classes 2-4 (OR 2.2, 95% CI 1.2-3.7).
CONCLUSION: Clinical characteristics of ICD patients can predict those at risk for inappropriate shock and should be considered for interventions to decrease such shocks.

Entities:  

Mesh:

Year:  2003        PMID: 12815308     DOI: 10.1023/a:1023973306742

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  8 in total

Review 1.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

2.  Does the rate of inappropriate therapy differ in implantable cardioverter-defibrillators from different manufacturers?

Authors:  Arash Arya; Majid Haghjoo; Zahra Emkanjoo; Mohammad Reza Dehghani; Mohammad Ali Sadr-Ameli
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

Review 3.  [Home Monitoring with implantable ICD--a diagnostic innovation?].

Authors:  W Jung; R Birkemeyer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2005-09

Review 4.  Approach to antiarrhythmic therapy in patients with ICDs and frequent activations.

Authors:  Arnold Pinter; Paul Dorian
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

5.  Predictors of implantable cardioverter defibrillator shocks during the first year.

Authors:  Cynthia M Dougherty; Jim Hunziker
Journal:  J Cardiovasc Nurs       Date:  2009 Jan-Feb       Impact factor: 2.083

6.  Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy.

Authors:  Anna Woo; Daniel Monakier; Louise Harris; Ann Hill; Prasad Shah; E Douglas Wigle; Harry Rakowski; Evelyn Rozenblyum; Douglas A Cameron
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

7.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesœs Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark McGuire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  J Arrhythm       Date:  2016-02-01

8.  Ventricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators.

Authors:  Uma N Srivatsa; Bobbi L Hoppe; Sanjiv Narayan; Gregory K Feld; Ulrika Birgersdotter-Green
Journal:  Indian Pacing Electrophysiol J       Date:  2007-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.